The study demonstrates that this RNAi approach shuts down vital fungal genes, thereby inhibiting pathogen growth - a ...

The firm said its next-generation siRNA candidate showed in preclinical studies that it could reduce tumor growth and metastatic spread.

The decision to expand the development plan follows recently reported promising preclinical findings demonstrating that ...

Unlocking the Potential of siRNA for Drug Development siRNA therapeutics represent a paradigm shift in targeted drug development by enabling precise gene silencing of disease-causing genes.

Fan Kelong and Yan Xiyun from the Institute of Biophysics of the Chinese Academy of Sciences introduces a novel ferritin-based delivery system for small interfering RNA (siRNA) targeting ...

Silexion Therapeutics completes development plan for next-generation siRNA candidate SIL204; plans to present at 2025 NeauxCancer Conference: Grand Cayman, Cayman Islands Tuesday, ...

Würzburg researchers present a new strategy against the life-threatening fungus Aspergillus fumigatus. They combine RNA ...

Novotech, a top global clinical trial provider, partners with biotech and pharma to speed siRNA therapeutic development.

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of ...